Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017 (2017), Article ID 2418671, 9 pages
https://doi.org/10.1155/2017/2418671
Review Article

Recent Advances of Curcumin in the Prevention and Treatment of Renal Fibrosis

1Preclinical Medicine School, Beijing University of Chinese Medicine, Beijing 100029, China
2Chinese Material Medical School, Beijing University of Chinese Medicine, Beijing 100029, China
3The Research Institute of McGill University Health Center, Montreal, QC, Canada H4A 3J1
4Diabetes Research Center, Beijing University of Chinese Medicine, Beijing 100029, China

Correspondence should be addressed to Dongwei Zhang; moc.liamg@6001iewgnod and Yu Li; moc.361@3791gnijiebuyil

Received 7 January 2017; Accepted 1 February 2017; Published 4 May 2017

Academic Editor: Ekaterina A. Ivanova

Copyright © 2017 Xuejiao Sun et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Kössler, C. Nofziger, M. Jakab, S. Dossena, and M. Paulmichl, “Curcumin affects cell survival and cell volume regulation in human renal and intestinal cells,” Toxicology, vol. 292, no. 2-3, pp. 123–135, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. D.-w. Zhang, M. Fu, S.-H. Gao, and J.-L. Liu, “Curcumin and diabetes: a systematic review,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 636053, 16 pages, 2013. View at Publisher · View at Google Scholar
  3. S. Prasad and B. Aggarwal, “Turmeric, the golden spice: from traditional medicine to modern medicine,” in Herbal Medicine: Biomolecular and Clinical Aspects, I. F. F. Benzie and S. Wachtel-Galor, Eds., pp. 263–288, CRC Press, Boca Raton, Fla, USA, 2011. View at Publisher · View at Google Scholar
  4. D. Lelli, A. Sahebkar, T. P. Johnston, and C. Pedone, “Curcumin use in pulmonary diseases: state of the art and future perspectives,” Pharmacological Research, vol. 115, pp. 133–148, 2017. View at Publisher · View at Google Scholar
  5. E. A. Jones, A. Shahed, and D. A. Shoskes, “Modulation of apoptotic and inflammatory genes by bioflavonoids and angiotensin II inhibition in ureteral obstruction,” Urology, vol. 56, no. 2, pp. 346–351, 2000. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Trujillo, Y. I. Chirino, E. Molina-Jijón, A. C. Andérica-Romero, E. Tapia, and J. Pedraza-Chaverrí, “Renoprotective effect of the antioxidant curcumin: recent findings,” Redox Biology, vol. 1, no. 1, pp. 448–456, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. L.-C. Li and L.-D. Kan, “Traditional Chinese medicine for pulmonary fibrosis therapy: progress and future prospects,” Journal of Ethnopharmacology, vol. 198, pp. 45–63, 2017. View at Publisher · View at Google Scholar
  8. J. Xia, L.-Q. He, and X. Su, “Interventional mechanisms of herbs or herbal extracts on renal interstitial fibrosis,” Journal of Integrative Medicine, vol. 14, no. 3, pp. 165–173, 2016. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. Liu, “Cellular and molecular mechanisms of renal fibrosis,” Nature Reviews Nephrology, vol. 7, no. 12, pp. 684–696, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. X.-M. Meng, D. J. Nikolic-Paterson, and H. Y. Lan, “Inflammatory processes in renal fibrosis,” Nature Reviews Nephrology, vol. 10, no. 9, pp. 493–503, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. B. Conway and J. Hughes, “Cellular orchestrators of renal fibrosis,” QJM, vol. 105, no. 7, pp. 611–615, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. D. J. Nikolic-Paterson, S. Wang, and H. Y. Lan, “Macrophages promote renal fibrosis through direct and indirect mechanisms,” Kidney International Supplements, vol. 4, no. 1, pp. 34–38, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. N. Kuwabara, S. Tamada, T. Iwai et al., “Attenuation of renal fibrosis by curcumin in rat obstructive nephropathy,” Urology, vol. 67, no. 2, pp. 440–446, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. L.-N. Sun, Z.-Y. Yang, S.-S. Lv, X.-C. Liu, G.-J. Guan, and G. Liu, “Curcumin prevents diabetic nephropathy against inflammatory response via reversing caveolin-1 Tyr14 phosphorylation influenced TLR4 activation,” International Immunopharmacology, vol. 23, no. 1, pp. 236–246, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. V. Soetikno, F. R. Sari, P. T. Veeraveedu et al., “Curcumin ameliorates macrophage infiltration by inhibiting NF-κB activation and proinflammatory cytokines in streptozotocin induced-diabetic nephropathy,” Nutrition and Metabolism, vol. 8, no. 1, article 35, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. S. S. Ghosh, H. D. Massey, R. Krieg et al., “Curcumin ameliorates renal failure in 5/6 nephrectomized rats: role of inflammation,” American Journal of Physiology—Renal Physiology, vol. 296, no. 5, pp. F1146–F1157, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Wada, K. Furuichi, N. Sakai et al., “Gene therapy via blockade of monocyte chemoattractant protein-1 for renal fibrosis,” Journal of the American Society of Nephrology, vol. 15, no. 4, pp. 940–948, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. K. Kitagawa, T. Wada, K. Furuichi et al., “Blockade of CCR2 ameliorates progressive fibrosis in kidney,” The American Journal of Pathology, vol. 165, no. 1, pp. 237–246, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Jacob, L. Chaves, M. T. Eadon, A. Chang, R. J. Quigg, and J. J. Alexander, “Curcumin alleviates immune-complex-mediated glomerulonephritis in factor-H-deficient mice,” Immunology, vol. 139, no. 3, pp. 328–337, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. F. Zhong, H. Chen, L. Han, Y. Jin, and W. Wang, “Curcumin attenuates lipopolysaccharide-induced renal inflammation,” Biological and Pharmaceutical Bulletin, vol. 34, no. 2, pp. 226–232, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. L.-N. Sun, Z.-X. Chen, X.-C. Liu, H.-Y. Liu, G.-J. Guan, and G. Liu, “Curcumin ameliorates epithelial-to-mesenchymal transition of podocytes in vivo and in vitro via regulating caveolin-1,” Biomedicine and Pharmacotherapy, vol. 68, no. 8, pp. 1079–1088, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. J. Huang, K. Huang, T. Lan et al., “Curcumin ameliorates diabetic nephropathy by inhibiting the activation of the SphK1-S1P signaling pathway,” Molecular and Cellular Endocrinology, vol. 365, no. 2, pp. 231–240, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. S. S. Ghosh, R. Krieg, H. D. Massey et al., “Curcumin and enalapril ameliorate renal failure by antagonizing inflammation in 5/6 nephrectomized rats: role of phospholipase and cyclooxygenase,” American Journal of Physiology—Renal Physiology, vol. 302, no. 4, pp. F439–F454, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. E. Tapia, Z. L. Zatarain-Barrón, R. Hernández-Pando et al., “Curcumin reverses glomerular hemodynamic alterations and oxidant stress in 5/6 nephrectomized rats,” Phytomedicine, vol. 20, no. 3-4, pp. 359–366, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. F. Zhong, H. Chen, Y. Jin, S. Guo, W. Wang, and N. Chen, “Analysis of the gene expression profile of curcumin-treated kidney on endotoxin-induced renal inflammation,” Inflammation, vol. 36, no. 1, pp. 80–93, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. R. M. Hashem, H. M. Soliman, and S. F. Shaapan, “Turmeric-based diet can delay apoptosis without modulating NF-κB in unilateral ureteral obstruction in rats,” Journal of Pharmacy and Pharmacology, vol. 60, no. 1, pp. 83–89, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. X. Zhou, J. Zhang, C. Xu, and W. Wang, “Curcumin ameliorates renal fibrosis by inhibiting local fibroblast proliferation and extracellular matrix deposition,” Journal of Pharmacological Sciences, vol. 126, no. 4, pp. 344–350, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Gaedeke, N. A. Noble, and W. A. Border, “Curcumin blocks fibrosis in anti-Thy 1 glomerulonephritis through up-regulation of heme oxygenase 1,” Kidney International, vol. 68, no. 5, pp. 2042–2049, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. R. Manikandan, R. Thiagarajan, S. Beulaja, G. Sudhandiran, and M. Arumugam, “Curcumin protects against hepatic and renal injuries mediated by inducible nitric oxide synthase during selenium-induced toxicity in Wistar rats,” Microscopy Research and Technique, vol. 73, no. 6, pp. 631–637, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Buyuklu, F. Mehmet Kandemir, M. Ozkaraca, T. Set, E. Murat Bakirci, and E. Topal, “Protective effect of curcumin against contrast induced nephropathy in rat kidney: what is happening to oxidative stress, inflammation, autophagy and apoptosis?” European Review for Medical and Pharmacological Sciences, vol. 18, no. 4, pp. 461–470, 2014. View at Google Scholar · View at Scopus
  31. J. Trujillo, E. Molina-Jijón, O. N. Medina-Campos et al., “Curcumin prevents cisplatin-induced decrease in the tight and adherens junctions: relation to oxidative stress,” Food and Function, vol. 7, no. 1, pp. 279–293, 2016. View at Publisher · View at Google Scholar · View at Scopus
  32. E. A. Abdel Fattah, H. E. Hashem, F. A. Ahmed, M. A. Ghallab, I. Varga, and S. Polak, “Prophylactic role of curcumin against cyclosporine-induced nephrotoxicity: histological and immunohistological study,” General Physiology and Biophysics, vol. 29, no. 1, pp. 85–94, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. H.-Y. Xue, L. Yuan, Y.-J. Cao, Y.-P. Fan, X.-L. Chen, and X.-Z. Huang, “Resveratrol ameliorates renal injury in spontaneously hypertensive rats by inhibiting renal micro-inflammation,” Bioscience Reports, vol. 36, no. 3, Article ID e00339, 2016. View at Publisher · View at Google Scholar · View at Scopus
  34. T. D. Gilmore, “Introduction to NF-κB: players, pathways, perspectives,” Oncogene, vol. 25, no. 51, pp. 6680–6684, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. R. P. Nagarajan, F. Chen, W. Li et al., “Repression of transforming-growth-factor-β-mediated transcription by nuclear factor κB,” Biochemical Journal, vol. 348, no. 3, pp. 591–596, 2000. View at Publisher · View at Google Scholar · View at Scopus
  36. F. Kayama, T. Yoshida, Y. Kodama, T. Matsui, J. M. Matheson, and M. I. Luster, “Pro-inflammatory cytokines and interleukin 6 in the renal response to bacterial endotoxin,” Cytokine, vol. 9, no. 9, pp. 688–695, 1997. View at Publisher · View at Google Scholar · View at Scopus
  37. Y. Pan, Y. Wang, L. Cai et al., “Inhibition of high glucose-induced inflammatory response and macrophage infiltration by a novel curcumin derivative prevents renal injury in diabetic rats,” British Journal of Pharmacology, vol. 166, no. 3, pp. 1169–1182, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Correa-Costa, P. Semedo, A. P. F. S. Monteiro et al., “Induction of heme oxygenase-1 can halt and even reverse renal tubule-interstitial fibrosis,” PLoS ONE, vol. 5, no. 12, Article ID e14298, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. X. Chen, S.-Y. Wei, J.-S. Li et al., “Overexpression of heme oxygenase-1 prevents renal interstitial inflammation and fibrosis induced by unilateral ureter obstruction,” PLoS ONE, vol. 11, no. 1, Article ID e0147084, 2016. View at Publisher · View at Google Scholar · View at Scopus
  40. P. M. Oliver, X. Cao, G. S. Worthen et al., “Ndfip1 protein promotes the function of itch ubiquitin ligase to prevent T cell activation and T helper 2 cell-mediated inflammation,” Immunity, vol. 25, no. 6, pp. 929–940, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. X. Che, Q. Wang, Y. Xie et al., “Astragaloside IV suppresses transforming growth factor-β1 induced fibrosis of cultured mouse renal fibroblasts via inhibition of the MAPK and NF-κB signaling pathways,” Biochemical and Biophysical Research Communications, vol. 464, no. 4, pp. 1260–1266, 2015. View at Publisher · View at Google Scholar · View at Scopus
  42. W. Wang, P.-H. Zhou, C.-G. Xu, X.-J. Zhou, W. Hu, and J. Zhang, “Baicalein attenuates renal fibrosis by inhibiting inflammation via down-regulating NF-κB and MAPK signal pathways,” Journal of Molecular Histology, vol. 46, no. 3, pp. 283–290, 2015. View at Publisher · View at Google Scholar · View at Scopus
  43. S. Akira, K. Takeda, and T. Kaisho, “Toll-like receptors: critical proteins linking innate and acquired immunity,” Nature Immunology, vol. 2, no. 8, pp. 675–680, 2001. View at Publisher · View at Google Scholar · View at Scopus
  44. G. H. Tesch, “Macrophages and diabetic nephropathy,” Seminars in Nephrology, vol. 30, no. 3, pp. 290–301, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. Y. B. Y. Sun, X. Qu, G. Caruana, and J. Li, “The origin of renal fibroblasts/myofibroblasts and the signals that trigger fibrosis,” Differentiation, vol. 92, no. 3, pp. 102–107, 2016. View at Publisher · View at Google Scholar · View at Scopus
  46. S. Hao, W. He, Y. Li et al., “Targeted inhibition of β-catenin/CBP signaling ameliorates renal interstitial fibrosis,” Journal of the American Society of Nephrology, vol. 22, no. 9, pp. 1642–1653, 2011. View at Publisher · View at Google Scholar · View at Scopus
  47. J. Heuberger and W. Birchmeier, “Interplay of cadherin-mediated cell adhesion and canonical Wnt signaling,” Cold Spring Harbor Perspectives in Biology, vol. 2, no. 2, Article ID a002915, 2010. View at Google Scholar
  48. F. Galbiati, D. Volonte, A. M. C. Brown et al., “Caveolin-1 expression inhibits Wnt/β-catenin/Lef-1 signaling by recruting β-catenin to caveolae membrane domains,” Journal of Biological Chemistry, vol. 275, no. 30, pp. 23368–23377, 2000. View at Publisher · View at Google Scholar · View at Scopus
  49. Y. Li, Z.-Q. Chen, and Y.-D. Li, “Effects of curcumin on the epithelial mesenchymal transition and TGF-beta/Smads signaling pathway in unilateral ureteral obstruction rats,” Zhongguo Zhong Xi Yi Jie He Za Zhi, vol. 31, no. 9, pp. 1224–1228, 2011. View at Google Scholar · View at Scopus
  50. R. Li, Y. Wang, Y. Liu et al., “Curcumin inhibits transforming growth factor-β1-induced EMT via PPARγ pathway, not smad pathway in renal tubular epithelial cells,” PLoS ONE, vol. 8, no. 3, Article ID e58848, 2013. View at Publisher · View at Google Scholar · View at Scopus
  51. X. Zhang, D. Liang, L. Guo et al., “Curcumin protects renal tubular epithelial cells from high glucose-induced epithelial-to-mesenchymal transition through Nrf2-mediated upregulation of heme oxygenase-1,” Molecular Medicine Reports, vol. 12, no. 1, pp. 1347–1355, 2015. View at Publisher · View at Google Scholar · View at Scopus
  52. Z. L. Li, L. Mo, G. Le, and Y. Shi, “Oxidized casein impairs antioxidant defense system and induces hepatic and renal injury in mice,” Food and Chemical Toxicology, vol. 64, pp. 86–93, 2014. View at Publisher · View at Google Scholar · View at Scopus
  53. E. Tapia, V. Soto, K. M. Ortiz-Vega et al., “Curcumin induces Nrf2 nuclear translocation and prevents glomerular hypertension, hyperfiltration, oxidant stress, and the decrease in antioxidant enzymes in 5/6 nephrectomized rats,” Oxidative Medicine and Cellular Longevity, vol. 2012, Article ID 269039, 2012. View at Publisher · View at Google Scholar · View at Scopus
  54. S. Boddupalli, J. R. Mein, S. Lakkanna, and D. R. James, “Induction of phase 2 antioxidant enzymes by broccoli sulforaphane: perspectives in maintaining the antioxidant activity of vitamins A, C, and E,” Frontiers in Genetics, vol. 3, article 7, 2012. View at Publisher · View at Google Scholar · View at Scopus
  55. T. Nguyen, P. Nioi, and C. B. Pickett, “The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress,” Journal of Biological Chemistry, vol. 284, no. 20, pp. 13291–13295, 2009. View at Publisher · View at Google Scholar · View at Scopus
  56. S.-Y. Lee, S. I. Kim, and M. E. Choi, “Therapeutic targets for treating fibrotic kidney diseases,” Translational Research, vol. 165, no. 4, pp. 512–530, 2015. View at Publisher · View at Google Scholar · View at Scopus
  57. J. Gaedeke, N. A. Noble, and W. A. Border, “Curcumin blocks multiple sites of the TGF-β signaling cascade in renal cells,” Kidney International, vol. 66, no. 1, pp. 112–120, 2004. View at Publisher · View at Google Scholar · View at Scopus
  58. C.-C. Zeng, X. Liu, W.-W. Liu et al., “Protective effect of curcumin derivative B06 on kidney of type 2 diabetic rats,” Chinese Journal of Applied Physiology, vol. 31, no. 1, pp. 38–42, 2015. View at Google Scholar · View at Scopus
  59. C. Xin, S. Ren, B. Kleuser et al., “Sphingosine 1-phosphate cross-activates the Smad signaling cascade and mimics transforming growth factor-β-induced cell responses,” The Journal of Biological Chemistry, vol. 279, no. 34, pp. 35255–35262, 2004. View at Publisher · View at Google Scholar · View at Scopus
  60. B. Ogretmen and Y. A. Hannun, “Biologically active sphingolipids in cancer pathogenesis and treatment,” Nature Reviews Cancer, vol. 4, no. 8, pp. 604–616, 2004. View at Publisher · View at Google Scholar · View at Scopus
  61. X.-Y. Fu, D.-W. Zhang, Y.-D. Li et al., “Curcumin treatment suppresses CCR7 expression and the differentiation and migration of human circulating fibrocytes,” Cellular Physiology and Biochemistry, vol. 35, no. 2, pp. 489–498, 2015. View at Publisher · View at Google Scholar · View at Scopus
  62. T. Xu, N.-S. Wang, L.-L. Fu, C.-Y. Ye, S.-Q. Yu, and C.-L. Mei, “Celecoxib inhibits growth of human autosomal dominant polycystic kidney cyst-lining epithelial cells through the VEGF/Raf/MAPK/ERK signaling pathway,” Molecular Biology Reports, vol. 39, no. 7, pp. 7743–7753, 2012. View at Publisher · View at Google Scholar · View at Scopus
  63. S. Sun, X. Ning, Y. Zhai et al., “Egr-1 mediates chronic hypoxia-induced renal interstitial fibrosis via the PKC/ERK pathway,” American Journal of Nephrology, vol. 39, no. 5, pp. 436–448, 2014. View at Publisher · View at Google Scholar · View at Scopus
  64. J. Ni, Y. Shen, Z. Wang et al., “P300-dependent STAT3 acetylation is necessary for angiotensin II-induced pro-fibrotic responses in renal tubular epithelial cells,” Acta Pharmacologica Sinica, vol. 35, no. 9, pp. 1157–1166, 2014. View at Publisher · View at Google Scholar · View at Scopus
  65. Q. Li, X. Liu, and J. Wei, “Ageing related periostin expression increase from cardiac fibroblasts promotes cardiomyocytes senescent,” Biochemical and Biophysical Research Communications, vol. 452, no. 3, pp. 497–502, 2014. View at Publisher · View at Google Scholar · View at Scopus
  66. Y. Wang, Y. Wang, M. Luo et al., “Novel curcumin analog C66 prevents diabetic nephropathy via JNK pathway with the involvement of p300/CBP-mediated histone acetylation,” Biochimica et Biophysica Acta—Molecular Basis of Disease, vol. 1852, no. 1, pp. 34–46, 2015. View at Publisher · View at Google Scholar · View at Scopus
  67. M. Pang, J. Kothapally, H. Mao et al., “Inhibition of histone deacetylase activity attenuates renal fibroblast activation and interstitial fibrosis in obstructive nephropathy,” American Journal of Physiology—Renal Physiology, vol. 297, no. 4, pp. F996–F1005, 2009. View at Publisher · View at Google Scholar · View at Scopus
  68. Y. Okunuki, Y. Usui, H. Nakagawa et al., “Peroxisome proliferator-activated receptor-γ agonist pioglitazone suppresses experimental autoimmune uveitis,” Experimental Eye Research, vol. 116, pp. 291–297, 2013. View at Publisher · View at Google Scholar · View at Scopus
  69. H. Kusunoki, Y. Taniyama, H. Rakugi, and R. Morishita, “Cardiac and renal protective effects of irbesartan via peroxisome proliferator-activated receptorγ-hepatocyte growth factor pathway independent of angiotensin II Type 1a receptor blockade in mouse model of salt-sensitive hypertension,” Journal of the American Heart Association, vol. 2, no. 2, Article ID e000103, 2013. View at Publisher · View at Google Scholar · View at Scopus
  70. E. L. Santos, K. de Picoli Souza, E. D. da Silva et al., “Long term treatment with ACE inhibitor enalapril decreases body weight gain and increases life span in rats,” Biochemical Pharmacology, vol. 78, no. 8, pp. 951–958, 2009. View at Publisher · View at Google Scholar · View at Scopus
  71. S. Zhao, Y. Mugabo, J. Iglesias et al., “α/β-Hydrolase domain-6-accessible monoacylglycerol controls glucose-stimulated insulin secretion,” Cell Metabolism, vol. 19, no. 6, pp. 993–1007, 2014. View at Publisher · View at Google Scholar · View at Scopus